Press Releases

Immunoglobulins Market to reach a market value of about US$ 20,757 Mn by the end of 2026

Share This Article

Global Immunoglobulins Market – Snapshot

The global immunoglobulins market is expected to reach a market value of about US$ 20,757 Mn by the end of 2026, expanding at a high single digit CAGR during the forecast period. Rise in prevalence of diseases related to neurology, immunology, hematology, and other deficiencies, rising geriatric population across the globe, leading to diseases, adoption, and awareness of effective immunoglobulins products, improving healthcare infrastructure, and rich product pipeline are expected to boost the global immunoglobulins market during the forecast period. Surge in investments by key players through collaborations, mergers, and acquisition are expected to propel the global immunoglobulins market during the forecast period. However, the high cost of treatments and severe side-effects associated with infusions are expected to hamper the immunoglobulins market. Niche rare disease segment with limited product availability is likely to fuel the market.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111969

The global immunoglobulins market has been segmented based on applications, route of administration, and end-user. In terms of applications, the global market has been classified into neurology, immunology, hematology, and others. The neurology segment dominates the global immunoglobulins market, in terms of value, owing to its indication prevalence. This immunology segment is expected to expand at a significant CAGR owing to higher prevalence of idiopathic thrombocytopenic purpura (ITP), primary immunodeficiency, and other indications. Based on route of administration, the global immunoglobulins market has been divided into intravenous, subcutaneous, and intramuscular. The intravenous segment held a major share of the market in 2017. It is expected to maintain its leading position, in terms of market share, during the forecast period owing to its rapid onset of action. However, benefits of subcutaneous over intravenous are presently slowly adaptable in the market and hence, the subcutaneous segment is projected to expand at a notable CAGR during the forecast period.

In terms of end-user, the global immunoglobulins market has been segregated into hospital, clinic, and homecare. The hospital segment held a major share of the market in 2017, followed by clinic and homecare segments, owing to the acceptance of advanced treatment requiring hospitalization. The homecare segment is projected to expand at a considerable CAGR during the forecast period owing to easy administration of infusions at home, supporting personal care, as well as it saves the cost of treatment. In developing countries, the medical care isn’t funded completely by the government; hence, the rising adoption of homecare is advantageous to patients. Preference of subcutaneous products is also driving the homecare segment

In terms of geography, the global immunoglobulins market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global immunoglobulins market owing to major acceptance of intravenous infusions, increasing plasma yield, healthcare investments by the government, and presence of major players in the region. According to the Immune Deficiency Foundation (IDF), there are more than 5 million undiagnosed cases in the U.S., which in turn is driving innovative therapeutic treatments and huge investments. Rising incidence of neurological, autoimmune disorders is boosting the demand for effective treatment, which in turn is a major factor driving the market in North America. The market in Asia Pacific is projected to expand at a significantly high CAGR during the forecast period, owing to improving health care infrastructure, rising investments in research and development, increasing disposable income, awareness about IVIG infusions in countries, such as China and India, and increasing acceptance of SCIG infusions in the region. IVIG accounts for a prominent share of the plasma market in China. Furthermore, the prevalence of CIDP, ITP diseases is anticipated to further boost the market in Asia Pacific in the near future.

View full report@ https://qyresearchmedical.com/report/immunoglobulins-market-applications-neurology-immunology-hematology-route-of-administration-intravenous-subcutaneous-intramuscular-end-user-hospital-clinic-homecare-global-industry-analysis-size-018-2030/111969

Major players operating in the global immunoglobulins market include Shire, CSL Behring, Kedrion Biopharma Inc, Grifols, S.A., Octapharma, China Biologic Products Holdings Inc, Biotest AG, Sanquin, and LFB SA. Key players are focusing on geographic expansion through acquisitions and collaborations to enhance their footprint in the global immunoglobulins market. Furthermore, companies are investing in pipeline products for building strong product portfolio.

IVIg Usage in Treating Severe COVID-19 Cases will bring Good Growth Opportunities for the Immunoglobulins Market

The immunoglobulins market is extrapolated to gain intensive growth opportunities owing to the increasing cases of immunodeficiency. The changing lifestyle habits and hectic work schedules have led to problems related to immunodeficiency. Thus, this aspect will bring good growth opportunities for the immunoglobulins market during the forecast period of 2018-2026.

Immunoglobulins are glycoproteins created in response to an immunogen by plasma cells and act as antibodies. They generally bind to antigenic determinants and eliminate the threat of infections. Hence, all these aspects bring exponential growth for the immunoglobulins market.

The booming geriatric population and a rise in the number of hemophilic patients will serve as a vital growth generator for the immunoglobulins market. The popularity of immunoglobulin therapy as the preferred treatment for immunodeficiency and other rare neurological diseases may invite exponential growth for the immunoglobulins market. The escalating focus on immune disorder diagnosis will serve as a prominent growth factor. Quick regulatory approvals are also helping in boosting the growth prospects of the immunoglobulins market.

Research and development activities are playing a crucial role in the growth of the immunoglobulins market. The players in the immunoglobulins market focus on these activities for discovering unique insights. The insights assist in boosting the revenues of the players in the immunoglobulins market, ultimately adding extra stars of growth.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111969/2900

The COVID-19 outbreak is one of the worst pandemics the world has ever faced. The rapid transmission rate and the high fatality rate have left many scientists and researchers searching for a good treatment option. Many options have been discovered by researchers and scientists. The utilization of immunoglobulins is one of them. The utilization of Intravenous immunoglobulin (IVIg) for treating serious COVID-19 patients is being considered by many scientists and researchers. A recent study also showcased the efficacy of IVIg in treating COVID-19 patients. Thus, this aspect can bring great growth opportunities for the immunoglobulins market.

The global immunoglobulins market has been segmented as below:

by Applications

  • Neurology
  • Immunology
  • Hematology
  • Others

by Route Of Administration

  • Intravenous
  • Subcutaneous
  • Intramuscular

by End-user

  • Hospital
  • Clinic
  • Homecare

by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • South Africa
  • GCC Countries
  • Rest of Middle East & Africa

TABLE OF CONTENT

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Immunoglobulins Market

4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Immunoglobulins Market Analysis and Forecast, 2016–2026
4.4.1. Global Immunoglobulins Market Value (US$ Mn) Projections
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Regulatory Scenario by Region/globally
5.3. Pipeline Analysis

6. Global Immunoglobulins Market Analysis and Forecast, by Applications
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Immunoglobulins Market Value Forecast, by Applications, 2016–2026
6.3.1. Neurology
6.3.2. Immunology
6.3.3. Hematology
6.3.4. Others
6.4. Global Immunoglobulins Market Attractiveness by Applications

7. Global Immunoglobulins Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
7.3.1. Intravenous
7.3.2. Subcutaneous
7.3.3. Intramuscular
7.4. Global Immunoglobulins Market Attractiveness by Route of Administration

8. Global Immunoglobulins Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Immunoglobulins Market Value Forecast, by End-user, 2016–2026
8.3.1. Hospital
8.3.2. Clinic
8.3.3. Homecare
8.4. Global Immunoglobulins Market Attractiveness by End-user

9. Global Immunoglobulins Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Immunoglobulins Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Immunoglobulins Market Attractiveness, by Country/Region

10. North America Immunoglobulins Market Analysis and Forecast

……

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111969/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Related Articles

Back to top button